The TRAIL: TRAILshort Axis in HIV Immunopathology

Area of Science:

• Immunology
• Virology
• Molecular Biology

Background:

• HIV infection leads to accelerated CD4 T-cell loss, causing immunodeficiency and susceptibility to opportunistic infections.
• Latent viral reservoirs and host defense manipulation are key challenges in HIV eradication.
• Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) plays a role in CD4 T-cell depletion during HIV infection.

Purpose of the Study:

• To review the role of the TRAIL: TRAILshort receptor axis in modulating immune cell apoptosis in HIV infection.
• To discuss how TRAIL and TRAILshort contribute to immune cell activation and HIV host defense.
• To explore HIV's mechanisms for manipulating TRAIL for viral survival.

Main Methods:

• Review of existing literature on TRAIL, TRAILshort, and their receptors in the context of HIV.
• Analysis of the molecular mechanisms underlying TRAIL-mediated apoptosis and TRAILshort's inhibitory function.
• Discussion of immune cell responses and HIV survival strategies related to the TRAIL pathway.

Main Results:

• Expression of TRAIL and its receptors is upregulated during HIV infection.
• A novel splice variant, TRAILshort, is present in HIV-infected patients' serum.
• TRAILshort binds death receptors without inducing apoptosis and inhibits TRAIL-mediated cell death, conferring resistance.

Conclusions:

• The TRAIL: TRAILshort axis is a critical modulator of immune cell apoptosis and survival in HIV infection.
• TRAILshort contributes to HIV persistence by conferring resistance to TRAIL-induced apoptosis.
• Understanding these mechanisms offers insights into HIV pathogenesis and potential therapeutic targets.